Novavax intends to file for regulatory authorizations for its COVID-19 vaccine in the third quarter and remains on track to reach a manufacturing capacity of 100 million doses per month by the end of the third quarter.
Supermarket operators are leveraging the entire store and the clinical capabilities of their pharmacists to reach patients and solidify their position as healthcare destinations.